30 Stocks Moving in Friday's Pre-Market Session

Gainers

• Navidea Biopharmaceuticals, Inc. NAVB shares rose 65.2% to $2.18 in pre-market trading after the company reported results of second interim analysis of ongoing Phase 2B study in rheumatoid arthritis.
• Tetraphase Pharmaceuticals, Inc. TTPH rose 47.8% to $3.40 in pre-market trading after the company announced determination of superior offer from Melinta Therapeutics, Inc.
• Sundial Growers Inc. SNDL rose 25.5% to $0.76 in pre-market trading after gaining over 9% on Thursday.
• Intec Pharma Ltd. NTEC rose 15.3% to $0.34 in pre-market trading after jumping 23% on Thursday.
• T2 Biosystems, Inc. TTOO rose 15% to $0.75 in pre-market trading.
• Bridgeline Digital, Inc. BLIN rose 12.6% to $1.70 in pre-market trading.
• Delek Logistics Partners, LP DKL rose 9% to $25.00 in pre-market trading.
• Entera Bio Ltd. ENTX rose 8.2% to $2.25 in pre-market trading. Entera Bio shares tumbled 27% on Thursday as the company announced interim limited biomarker data from the ongoing Phase 2 clinical trial of EB613 in osteoporosis patients, with the study demonstrating statistically significant effects on the P1NP biomarker after one month of treatment as compared to placebo, and meaningful increases at months two and three as compared to placebo with the highest EB613 dose of 1.5mg.
• Oncolytics Biotech Inc. ONCY rose 7.3% to $2.81 in pre-market trading after declining 5% on Thursday.
• Palo Alto Networks Inc PANW rose 7.2% to $246.00 in pre-market trading after the company reported better-than-expected Q3 results. The company also issued FY20 guidance above estimates.
• Conatus Pharmaceuticals Inc. CNAT rose 7% to $0.62 in pre-market trading after declining 13% on Thursday.
• Celsion Corporation CLSN rose 6.8% to $2.51 in pre-market trading after jumping over 36% on Thursday.
• Agilent Technologies Inc A rose 5.3% to $85.00 in pre-market trading after the company reported better-than-expected Q2 results.
• Buckle Inc BKE rose 4% to $16.38 in pre-market trading following Q1 results.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Syndax Pharmaceuticals, Inc. SNDX fell 19.5% to $16.50 in pre-market trading after the company reported receipt of final results from Phase 3 E2112 trial of entinostat plus exemestane in patients with HR+, HER2- breast cancer. The trial did not achieve primary endpoint.
• Geron Corporation GERN fell 18.8% to $1.59 in pre-market trading after the company announced a proposed public offering of common stock and warrants..
• Akari Therapeutics, Plc AKTX shares fell 15% to $1.70 in pre-market trading. On Thursday, Akari Therapeutics received positive EMA opinion on orphan designation for nomacopan for bullous pemphigoid.
• PDS Biotechnology Corporation PDSB fell 14% to $1.05 in pre-market trading after surging 17% on Thursday.
• Sonim Technologies, Inc. SONM shares fell 13.8% to $0.9135 in pre-market trading after rising 15% on Thursday.
• Xtant Medical Holdings, Inc. XTNT fell 13.3% to $1.51 in pre-market trading after jumping 160% on Thursday.
• Hoth Therapeutics, Inc. HOTH fell 12.6% to $2.77 in pre-market trading after the company priced underwritten public offering of 1.8 million shares at $2.75 per share.
• Lattice Semiconductor Corporation LSCC fell 12.4% to $20.97 in pre-market trading.
• ContraFect Corp CFRX fell 10% to $4.85 in pre-market trading after the company announced a proposed public offering of common stock and warrants.
• I-Mab IMAB fell 9.9% to $20.00 in pre-market trading. On Thursday, I-Mab and Genexine reported China NMPA clearance for Phase 2 clinical trial of TJ107/HyLeukin-7 in glioblastoma multiforme.
• Monolithic Power Systems, Inc. MPWR fell 9.3% to $183.62 in pre-market trading.
• MaxLinear, Inc. MXL fell 8.6% to $14.90 in pre-market trading after dropping over 6% on Thursday.
• Dynavax Technologies Corporation DVAX shares fell 8.1% to $5.20 in pre-market trading after the company announced a proposed public offering of common stock.
• Nano Dimension Ltd. NNDM fell 5.5% to $2.92 in pre-market trading.
• Hewlett Packard Enterprise Co HPE fell 5.4% to $9.80 in pre-market trading after the company reported weaker-than-expected Q2 results.
• GDS Holdings Limited GDS fell 5% to $56.60 in pre-market trading after declining over 5% on Thursday.